01 NICARDIPINE HYDROCHLORIDE (3)
01 CHIESI (3)
01 CAPSULE, EXTENDED RELEASE;ORAL (3)
01 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (3)
19
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .
proudly manufactured in the
approval since 1992-02-21
CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.
18
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .
proudly manufactured in the
approval since 1992-02-21
CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.
17
CHIESI USA INC, based in U.S.A, is a pharmaceutical company.
One of their notable products is NICARDIPINE HYDROCHLORIDE, with a corresponding application number 20005 and regulatory information .
proudly manufactured in the
approval since 1992-02-21
CHIESI USA INC's CARDENE SR CAPSULE, EXTENDED RELEASE;ORAL, medication with 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of NICARDIPINE HYDROCHLORIDE.